Mechanism-based concepts of size and maturity in pharmacokinetics
- PMID: 17914927
- DOI: 10.1146/annurev.pharmtox.48.113006.094708
Mechanism-based concepts of size and maturity in pharmacokinetics
Abstract
Growth and development can be investigated using readily observable demographic factors such as weight and age. Size is the primary covariate and can be referenced to a 70-kg person with allometry using a coefficient of 0.75 for clearance and 1 for volume. The use of these coefficients is supported by fractal geometric concepts and observations from diverse areas in biology. Fat free mass (FFM) might be expected to do better than total body weight when there are wide variations in fat affecting body composition. Clearance pathways develop in the fetus before birth. The use of postnatal age as a descriptor of maturation is unsatisfactory because birth may occur prematurely; therefore postmenstrual age is a superior predictor of elimination function. A sigmoid E(max) model (Hill equation) describes gradual maturation of clearance in early life leading to a mature adult clearance achieved at a later age.
Similar articles
-
Pediatric models for adult target-controlled infusion pumps.Paediatr Anaesth. 2010 Mar;20(3):223-32. doi: 10.1111/j.1460-9592.2009.03072.x. Epub 2009 Jul 13. Paediatr Anaesth. 2010. PMID: 19627530 Review.
-
Tips and traps analyzing pediatric PK data.Paediatr Anaesth. 2011 Mar;21(3):222-37. doi: 10.1111/j.1460-9592.2011.03536.x. Paediatr Anaesth. 2011. PMID: 21320233 Review.
-
Population Pharmacokinetics: Some Observations in Pediatric Modeling for Drug Clearance.Clin Pharmacokinet. 2017 Dec;56(12):1567-1576. doi: 10.1007/s40262-017-0542-4. Clin Pharmacokinet. 2017. PMID: 28405936
-
Prediction of drug clearance in children.J Clin Pharmacol. 2015 Jul;55(7):739-47. doi: 10.1002/jcph.488. Epub 2015 May 25. J Clin Pharmacol. 2015. PMID: 25721251
-
Lean body mass as a predictor of drug dosage. Implications for drug therapy.Clin Pharmacokinet. 1994 Apr;26(4):292-307. doi: 10.2165/00003088-199426040-00005. Clin Pharmacokinet. 1994. PMID: 8013162 Review.
Cited by
-
Integration of preclinical and clinical knowledge to predict intravenous PK in human: bilastine case study.Eur J Drug Metab Pharmacokinet. 2014 Mar;39(1):33-41. doi: 10.1007/s13318-013-0131-3. Epub 2013 Apr 26. Eur J Drug Metab Pharmacokinet. 2014. PMID: 23619917
-
Model-based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicin.Br J Clin Pharmacol. 2013 Nov;76(5):741-51. doi: 10.1111/bcp.12101. Br J Clin Pharmacol. 2013. PMID: 23432610 Free PMC article. Clinical Trial.
-
Prediction of Fat-Free Mass in Children.Clin Pharmacokinet. 2015 Nov;54(11):1169-78. doi: 10.1007/s40262-015-0277-z. Clin Pharmacokinet. 2015. PMID: 25940825
-
Population pharmacokinetics of cyclosporine A in pediatric patients with thalassemia undergoing allogeneic hematopoietic stem cell transplantation.Eur J Clin Pharmacol. 2024 May;80(5):685-696. doi: 10.1007/s00228-024-03641-5. Epub 2024 Feb 8. Eur J Clin Pharmacol. 2024. PMID: 38329479
-
Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease.Br J Clin Pharmacol. 2015 Nov;80(5):1197-207. doi: 10.1111/bcp.12710. Epub 2015 Sep 5. Br J Clin Pharmacol. 2015. PMID: 26138279 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical